[et_pb_section fb_built=”1″ _builder_version=”4.14.1″ _module_preset=”default” locked=”off” collapsed=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.14.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.14.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_text admin_label=”Text” _builder_version=”4.14.1″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
Conference Report (7 Dec, 2017):<\/b><\/span> On 21 September 2016, the UN General Assembly (UNGA) convened a high-level meeting of Heads of States and national delegations to discuss an issue of increasing concern to national public health authorities around the world:\u00a0 the rise of antimicrobial resistance (AMR).\u00a0 As an indication of the urgency and magnitude of the problem, this was only the fourth time that a health topic had been raised for discussion by the General Assembly.\u00a0 A draft political declaration was issued in the wake of the meeting endorsing the Global Action Plan on Antimicrobial Resistance formulated by the World Health Organization in collaboration with the UN Food and Agriculture Organization and the World Organization for Animal Health.<\/p>\n The scale of the threat posed by AMR, and its current and potential toll in terms of deaths, human suffering and economic loss is immense.\u00a0 Current conservative estimates are that 700,000 people die from resistant infections each year.\u00a0 Of these, 200,000 people die from tuberculosis alone, as commonly-used antibiotics begin to lose to their efficacy because of AMR.\u00a0 Beyond the direct cost in human lives, it is estimated that more than 2 million infections a year are caused by resistant bacteria, which imposes an additional burden of US$20 billion on the US health care system alone.\u00a0 The human cost in countries that cannot afford such extra spending on healthcare is incalculable.\u00a0 Inappropriate use of antibiotics in livestock farming have accelerated the pace of the development of AMR, at once reducing the efficacy of critical antibiotics and leaking residual drugs into the environment and the food chain.\u00a0 It is estimated that over 70% by weight of the most important antibiotics are used on animals \u2013 and mostly for purposes other than for treating sick animals.\u00a0 The grim projection is that by 2050, the direct toll of human lives lost to AMR could rise to 10 million with a corresponding cumulative cost to global economic output of US$100 trillion (all data from O\u2019Neill et al, Tackling Drug-Resistant Infections Globally:\u00a0 Final Report and Recommendations, 2016:\u00a0 The Wellcome Trust \/ HM Government).<\/p>\n Themes:<\/strong>\u00a0This conference sets out in the\u00a0first session (\u2018The Challenge\u2019)\u00a0<\/strong>to present a survey of the present global scale and impact of AMR, and the implications for the future in human, clinical and economic costs if current trends in AMR is not reversed or contained. Current international efforts in building a concerted global response towards the containment of AMR will be examined, with especially reference to efforts by international agencies such as the World Health Organization.<\/p>\n The conference will then address next in its\u00a0second session (\u2018Emergent Threats \u2013 The Experience\u2019)<\/strong>\u00a0specific shortcomings and problem areas such as public and professional awareness; in public and environmental health (public sanitation and access to safe water); and in clinical practice in both developed and developing countries (short or inappropriate courses of antibiotics, resistant nosocomial infections in hospital settings, the problem of counterfeit antibiotics). We also look into recent developments in relevant technologies, such as in pathogen genomics.<\/p>\n In the\u00a0third session (\u2018The Community Context\u2019)<\/strong>\u00a0the conference will address specific situations in which AMR is already a grave and urgent threat (tuberculosis, malaria, MRSA and other resistant nosocomial infections), and examine accounts of current public health responses to the challenges of AMR for these specific situations, and consider recommendations for the future management of these conditions (including the incentivization of research, the development of new antibiotics and the prioritizing of resources to public health efforts at the control of these infections).\u00a0 The legal and ethical implications of some public health challenges are examined.\u00a0 The inappropriate use of antibiotics in animal agriculture is considered, as well as on its impact on the environment and the food chain, as well as recommended responses.<\/p>\n In the final and\u00a0fourth session (\u2018Making It Work\u2019)<\/strong>, the conference will focus on public health and national responses recommended by expert bodies such as the WHO in its global action plan on AMR, and the O\u2019Neill Report.\u00a0 How much will it take to stem the tide of AMR?\u00a0 What will be the corresponding financial cost of failure?\u00a0 What should the relative distribution of burdens and responsibilities between better-off and poorer nations, and how can communities in the latter be helped?<\/p>\n Guest of Honour:<\/strong><\/span><\/p>\n Professor Sophia CHAN Siu-Chee, JP, Secretary for Food and Health, The Government of HKSAR<\/strong><\/p>\n Speakers and Panelists:<\/span> \u00a0\u00a0\u00a0 \u00a0 Professor Dame Sally DAVIES<\/strong> Ms Christy FEIG<\/strong> Professor Keiji FUKUDA<\/strong> Professor Lawrence GOSTIN<\/strong> Dr Christopher Kim Ming HUI<\/strong> Associate Professor Li-Yang HSU<\/strong> Professor Ryuichi IDA<\/strong> Dr Timothy JINKS<\/strong> Mr Jeremy KNOX<\/strong> Dr Leila LUHESHI<\/strong> Professor Ben MARAIS<\/strong> Dr Colm McGRATH<\/strong> Professor SETO Wing-Hong<\/strong> Professor Hongzhe SUN<\/strong> Professor Paul TURNER<\/strong> Dr Howard WONG<\/strong> Professor YUEN Kwok-Yung<\/strong> Professor ZHANG Tong<\/strong> Registration Fee:<\/strong><\/span><\/p>\n For Public:<\/strong> Registration:<\/strong><\/span> Conference Programme:<\/strong> CME Accreditation by Colleges of Hong Kong Academy of Medicine\uff1a
Click\u00a0here<\/a><\/span><\/p>\n
<\/strong>
Ms Sabrina So-Kuen CHAN<\/strong>
Member of the Hong Kong High-Level Steering Committee on Antimicrobial Resistance, and Senior Executive Director of The Hong Kong Association of the Pharmaceutical Industry<\/p>\n
Chief Medical Officer, England<\/p>\n
Senior Vice President, Global Health Strategies<\/p>\n
Director, School of Public Health, The University of Hong Kong<\/p>\n
University Professor, Georgetown University; Faculty Director of the O\u2019Neill Institute for National and Global Health Law and the Founding O\u2019Neill Chair in Global Health Law<\/p>\n
The University of Hong Kong; HKU Shenzhen<\/p>\n
Programme Leader, AMR Programme, Saw Swee Hock School of Public Health, the National University of Singapore<\/p>\n
President, Shiga University, Japan; former Chairperson, International Bioethics Committee of UNESCO<\/p>\n
Senior Business Analyst, Wellcome Trust<\/p>\n
Policy Lead, Drug-Resistant Infections, Wellcome Trust<\/p>\n
Associate Director, Clinical and Translational Research at Oxford Nanopore Technologies Ltd; formerly Head of Science, The PHG Foundation, Cambridge<\/p>\n
Professor, The Children\u2019s Hospital at Westmead Clinical School, Sydney<\/p>\n
Faculty of Law, University of Cambridge<\/p>\n
WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, The University of Hong Kong<\/p>\n
Department of Chemistry, The University of Hong Kong<\/p>\n
Director, Cambodia-Oxford Medical Research Unit (COMRU)<\/p>\n
College of Veterinary Medicine and Life Sciences, City University of Hong Kong<\/p>\n
The University of Hong Kong; Member of the Hong Kong Steering Committee on Antimicrobial Resistance<\/p>\n
Department of Civil Engineering, The University of Hong Kong<\/p>\n
Day 1 and Day 2 : HKD$200 (HKD$100 per day)
For HKU staff\/students: Free of Charge
(Please prepare to submit a soft copy of your HKU staff\/student Card and fill in a HKU email account for online registration)<\/p>\n
For Public, click\u00a0HERE<\/a><\/span>
For HKU staff\/student, click\u00a0HERE<\/a><\/span><\/p>\n
Click\u00a0here<\/a><\/span><\/p>\n
<\/strong>Click\u00a0here<\/a><\/span><\/p>\n